Madrigal Pharmaceuticals · 2 weeks ago
Associate Director, Specialty and IDN Operations
Springfield, Massachusetts Metropolitan Area
Full-time
Hybrid
Lead/Staff, Director/Executive
$182K/yr - $222K/yr
10+ years expMadrigal Pharmaceuticals is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The Associate Director, Specialty and IDN Operations is responsible for directing specialty pharmacy operations, enhancing patient access, and collaborating with internal and external stakeholders to implement impactful solutions.
BiopharmaBiotechnologyMedical DevicePharmaceutical
Responsibilities
Acquire and maintain deep understanding of NASH disease state, Rezdiffra™ clinical data and commercialization strategy
Closely monitor SP and IDN performance to ensure contractual obligations are meeting / exceeding obligations
Implement specialty pharmacy program services, enhancements, and operational efficiencies with the goal of positively impacting patient access, adherence, awareness, and affordability
Maintain SP and IDN program correspondence, scripting, and collateral via internal legal and regulatory approval processes
Partner with internal operations and data analytics teams to continuously evaluate and analyze specialty pharmacy vendor performance relative to goals and objectives
Lead Quarterly Business Reviews (QBR’s) and other summits with specialty pharmacies; prepare all materials, communicate expectations to vendors, and continuously drive performance while identifying key insights to incorporate into strategic planning efforts
Collaborate closely with Consumer Marketing and Patient Access teams to enhance SP program to continuously meet the needs of HCP’s and patients Develop and communicate key messages to internal and external channel partners
Oversee operational plans, project budgets, expenses, and timelines
Create and maintain necessary policies, procedures, and business rules for all distribution programs Consistently deliver measurable business outcomes based on program-level key performance indicators (KPIs) and provide timely program-level reporting to leadership
Consistently deliver outcomes with cross functional impact, tackle projects with increased complexity, and influence change management to operations function across internal teams
Ensure the highest level of ethics, quality, and compliance by demonstrating in depth knowledge of laws that govern market access and channel activities
Conducts all activities in compliance with all applicable federal, state and local laws and regulations and company policies
Qualification
Required
Bachelor's degree required; advanced degree in Business or Pharmacy preferred
10+ years of related experience in the biopharma industry with a proven, consistent history of high performance in a broad range of leadership roles of increasing responsibilities
3 - 5 years of healthcare industry customer/vendor management experience strongly preferred
3+ years of experience operationalizing specialty pharmacy programs and networks required
Ability to develop insights from data trends to improve program performance
Ability to work effectively within a cross-functional team and in an environment of rapid change
Excellent written, organizational, verbal, presentation, and communication skills a must
Proficient in MS Office products including PowerPoint, Word, and Excel
Travel (approximately 40%)
Preferred
Experience With Pre-launch Drugs And New Product Launches Preferred
Benefits
Flexible paid time off
Medical, dental, vision and life/disability insurance
401(k) offerings (i.e., traditional, Roth, and employer match)
Supplemental life insurance
Legal services
Mental health benefits through our Employee Assistance Program for employees and their family
Company
Madrigal Pharmaceuticals
Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.94BKey Investors
Blue OwlHercules Capital
2025-07-22Post Ipo Debt· $350M
2024-03-18Post Ipo Equity· $690M
2023-09-28Post Ipo Equity· $500M
Leadership Team
Mardi C. Dier
Chief Financial Officer
Carole Huntsman
Chief Commercial Officer (CCO)
Recent News
2026-01-19
Company data provided by crunchbase